The Day After

The United States of America went to the polls yesterday to elect their new President.  Now that all the votes have been cast and it is apparent that the next President will be Barack Obama, it is time to crunch the numbers and determine what effects (both positive and/or negative) can be expected in future for the life sciences industry.

The Obama-Biden Healthcare Plan has four points of focus:

1.     Invest in Health Information Technology Systems

2.     Improve Access to Prevention and Proven Disease Management Programs

3.     Lower Costs by Taking on Anticompetitive Actions in the Drug and Insurance Companies

4.     Reduce Costs of Catastrophic Illness for Employers and their Employees

 

No one can forecast for certain what effect this will have for American patients, providers, and private industry, but some trends should be apparent.